ImExHS Stock Price, News & Analysis (ASX:IME) Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.09 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A About ImExHSImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is headquartered in Mascot, Australia.Read More IME Stock News HeadlinesNovember 29, 2023 | tmcnet.comTeleradiology Market to Reach $46.7 Billion, Globally, by 2032 at 18.1% CAGR: Allied Market ResearchSeptember 5, 2023 | finance.yahoo.comImExHS First Half 2023 Earnings: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)December 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!July 15, 2023 | finance.yahoo.comInsider Stock Buying Reaches AU$1.1m On ImExHSJuly 4, 2023 | uk.finance.yahoo.comRadiology Services Global Market Report 2023April 17, 2023 | finance.yahoo.comImExHS Limited (ASX:IME) Could Be Riskier Than It LooksFebruary 4, 2023 | yahoo.comBullish insiders at ImExHS Limited (ASX:IME) loaded up on AU$1.1m of stock earlier this yearJuly 31, 2022 | afr.comCelsius Resources, Change Financial, Mighty Kingdom in placementsDecember 1, 2023 | Tomorrow Investor (Ad)Why Microsoft Just Placed A Huge Bet On NuclearEven with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.May 4, 2022 | finance.yahoo.comHealth Check: How Prudently Does ImExHS (ASX:IME) Use Debt?March 19, 2022 | finance.yahoo.comMultiple insiders bought ImExHS Limited (ASX:IME) stock earlier this year, a positive sign for shareholdersJanuary 19, 2022 | finance.yahoo.comBreakeven Is Near for ImExHS Limited (ASX:IME)October 9, 2021 | uk.finance.yahoo.comAdele credits gruelling gym sessions with helping her to combat anxietyOctober 9, 2021 | nz.finance.yahoo.comINDUS Announces Fiscal 2021 Third Quarter Earnings CallOctober 9, 2021 | nz.finance.yahoo.comAndy Murray Says He's in Hot Water 'at Home' After Wedding Ring Was Stolen While Tied to His ShoesOctober 7, 2021 | finance.yahoo.comDouglas Lingard Is The Independent Non-Executive Director of ImExHS Limited (ASX:IME) And They Just Picked Up 6.6% More SharesAugust 12, 2021 | finance.yahoo.comMarket Sentiment Around Loss-Making ImExHS Limited (ASX:IME)July 25, 2021 | msn.comASX health stocks: 4D Medical leads after ramping up its game in the USMay 14, 2021 | finance.yahoo.comInsider Buying: The ImExHS Limited (ASX:IME) Independent Non-Executive Director Just Bought 8.7% More SharesMay 4, 2021 | finance.yahoo.comImExHS (ASX:IME) Shareholders Booked A 30% Gain In The Last YearApril 9, 2021 | msn.comScoPo’s powerplays: Antisense ‘looks like it wants to run harder’April 2, 2021 | msn.comScoPo’s powerplays: Look to Mach7, Volpara and IMEXHS as quarterly reports nearMarch 4, 2021 | finance.yahoo.comWhen Will ImExHS Limited (ASX:IME) Breakeven?February 14, 2021 | msn.comScoPo’s health powerplays: What to look for this earnings seasonNovember 4, 2020 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of ImExHS Limited (ASX:IME) Shares?October 8, 2020 | ca.finance.yahoo.comImExHS Limited (IME.AX)August 4, 2020 | msn.comHow tech is changing healthcare, and where professional ASX investors are lookingSee More Headlines Receive IME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImExHS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2019Today12/01/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolASX:IME CUSIPN/A CIKN/A Webimexhs.com Phone57 1 316 4890FaxN/AEmployees300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,590,000.00 Net Margins-21.70% Pretax MarginN/A Return on Equity-22.33% Return on Assets-4.87% Debt Debt-to-Equity Ratio5.78 Current Ratio1.72 Quick Ratio1.24 Sales & Book Value Annual Sales$16.53 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.50 Book ValueA$0.40 per share Price / BookN/AMiscellaneous Outstanding Shares42,610,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.37 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. German ArangoCo-Founder, CEO, MD & DirectorMs. Reena MinhasCFO & Company SecretaryDr. Jorge MarinCo-Founder & Chief Medical OfficerMr. Andres VanegasCo-Founder & Strategic Accounts ManagerMr. Alexander SanzCo-Founder & CTOMr. Orlando JovenChief Operating OfficerMr. Juan Sebastian BonnetHead of SalesMr. Benjamin BrinquisHead of GrowthMore ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersCarlos PalacioSold 403,066 sharesTotal: $255,946.91 ($0.64/share)Douglas (Doug) FlynnSold 286,378 sharesTotal: $177,554.36 ($0.62/share)Douglas (Doug) FlynnBought 119,540 shares on 9/6/2023Total: $77,103.30 ($0.65/share)Carlos PalacioSold 39,726 sharesTotal: $23,835.60 ($0.60/share)German ArangoSold 162,182 sharesTotal: $97,309.20 ($0.60/share) IME Stock Analysis - Frequently Asked Questions How were ImExHS's earnings last quarter? ImExHS Limited (ASX:IME) posted its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. ImExHS had a negative trailing twelve-month return on equity of 22.33% and a negative net margin of 21.70%. This page (ASX:IME) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImExHS Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.